Table 4.

Organ radiation dosimetry calculations of [¹¹C]3MeO4AP using OLINDA software. Mean and range of values (n = 2)

Target organ	ED contribution ICPR 60 (μSv/MBq)		ED contribution ICPR 103 (μSv/MBq)
Adrenals	0.028 ± 0.006		0.11 ± 0.03
Brain	0.012 ± 0.001		0.051 ± 0.004
Breasts	0.11 ± 0.02		0.26 ± 0.05
Gallbladder wall	0		0.035 ± 0.004
LLI wall	0.25 ± 0.02		0.25 ± 0.02
Small intestine	0.010 ± 0.002		0.039 ± 0.008
Stomach wall	0.30 ± 0.04		0.30 ± 0.04
ULI wall	0.006 ± 0.001		0.30 ± 0.04
Heart wall	0		0.158 ± 0.006
Kidneys	0.98 ± 0.04		0.362 ± 0.014
Liver	0.58 ± 0.10		0.46 ± 0.08
Lungs	0.42 ± 0.04		0.42 ± 0.04
Muscle	0.006 ± 0.006		0.023 ± 0.003
Ovaries	0.70		0.28
Pancreas	0.018 ± 0.003		0.066 ± 0.013
Red marrow	0.25 ± 0.05		0.25 ± 0.05
Osteogenic cells	0.031 ± 0.011		0.032 ± 0.012
Skin	0.011 ± 0.002		0.011 ± 0.002
Spleen	0.020 ± 0.001		0.073 ± 0.001
Testes	0.60		0.24
Thymus	0.008 ± 0.001		0.029 ± 0.003
Thyroid	0.36 ± 0.06		0.29 ± 0.05
Urinary bladder wall	0.20 ± 0.15		0.16 ± 0.12
Uterus	0.010 ± 0.009		0.04 ± 0.03
Effective dose (μSv/MBq)	Male	Female	Male	Female
	3.9	4.7	3.6	4.4
Mean effective dose (μSv/MBq)	4.3 ± 0.6		4.0 ± 0.6